Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Tata Nifty MidSmall Healthcare Index Fund (G) Direct |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.06 |
Equity |
100.03 |
Trep |
0.03 |
|
|
Concentration Analysis |
Top 5 Holdings |
40.57% |
Top 10 Holdings |
61.96% |
Top 25 Holdings |
94.32% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
62.15 |
Healthcare |
37.88 |
Cash |
-0.03 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
6.08 |
PE Ratio |
45.77 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Max Healthcare Institute Limited |
15.01 |
Lupin Limited |
7.56 |
Fortis Health Care Ltd |
7.24 |
Laurus Labs Limited |
5.55 |
Glenmark Pharmaceuticals Limited |
5.21 |
Aurobindo Pharma Limited |
5.17 |
Mankind Pharma Limited |
4.70 |
Alkem Laboratories Limited |
4.39 |
Biocon Limited |
3.81 |
IPCA Laboratories Limited |
3.32 |
Krishna Inst of Medical Sciences Ltd. |
2.99 |
Abbott India Limited |
2.91 |
Gland Pharma Limited |
2.66 |
J B Chemicals and Pharma Ltd |
2.32 |
Aster DM Healthcare Limited |
2.21 |
Syngene International Limited |
2.19 |
Glaxosmithkline Pharma Ltd |
2.12 |
Narayana Hrudalaya Ltd |
2.11 |
Cohance Lifesciences Limited |
2.07 |
Piramal Pharma Limited |
1.98 |
Dr Lal Path Labs Ltd |
1.91 |
Ajanta Pharma Limited |
1.88 |
Neuland Laboratories Limited |
1.84 |
EQ- GLOBAL HEALTH LTD. |
1.79 |
Natco Pharma Limited |
1.38 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|